BIIB021 Completed Phase 1 Trials for Tumors / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00345189Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors